We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $8.43B
1-Year Est. Return 52.02%
This Fund
S&P 500
This Quarter Est. Return
+25.07%
1 Year Est. Return
+52.02%
3 Year Est. Return
+115.13%
5 Year Est. Return
+140.59%
10 Year Est. Return
+558.15%
AUM
$8.43B
AUM Growth
+$1.45B
Cap. Flow
+$163M
Cap. Flow %
1.93%
Top 10 Hldgs %
12.93%
Holding
678
New
102
Increased
209
Reduced
234
Closed
88

Top Buys

Rank Stock Value
1
TKR icon
Timken Company
TKR
+$45.3M
2
MARA icon
Marathon Digital Holdings
MARA
+$34.5M
3
LLY icon
Eli Lilly
LLY
+$29M
4
AVT icon
Avnet
AVT
+$26.8M
5
IEX icon
IDEX
IEX
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Industrials 21.43%
3 Financials 13.12%
4 Healthcare 12.2%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTSG icon
526
BrightSpring Health Services
BTSG
$12B
$1.22M 0.01%
17,563
-40,189
-70% -$2.23M
SUPN icon
527
Supernus Pharmaceuticals
SUPN
$2.53B
$1.21M 0.01%
25,931
+2,762
+12% +$133K
AGGY icon
528
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$906M
$1.2M 0.01%
27,661
-1,067
-4% -$46.5K
ASTH icon
529
Astrana Health
ASTH
$1.91B
$1.2M 0.01%
+25,826
New +$929K
PANL icon
530
Pangaea Logistics
PANL
$560M
$1.19M 0.01%
+183,584
New +$1.39M
OMCL icon
531
Omnicell
OMCL
$1.57B
$1.14M 0.01%
+27,493
New +$1.11M
PRGO icon
532
Perrigo
PRGO
$2.07B
$1.11M 0.01%
+106,931
New +$1.18M
TDC icon
533
Teradata
TDC
$2.61B
$1.11M 0.01%
+32,015
New +$974K
HRMY icon
534
Harmony Biosciences
HRMY
$2.46B
$1.09M 0.01%
30,059
COLL icon
535
Collegium Pharmaceutical
COLL
$766M
$1.09M 0.01%
30,116
+7,797
+35% +$266K
VIPS icon
536
Vipshop
VIPS
$6.28B
$1.07M 0.01%
80,500
CMC icon
537
Commercial Metals
CMC
$7.77B
$1.06M 0.01%
16,910
-120
-0.7% -$8.44K
INVA icon
538
Innoviva
INVA
$1.54B
$1.04M 0.01%
45,762
+5,529
+14% +$127K
RSPT icon
539
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.85B
$1.03M 0.01%
16,000
HUN icon
540
Huntsman Corp
HUN
$1.69B
$1.02M 0.01%
96,439
IONQ icon
541
IonQ
IONQ
$16B
$1.02M 0.01%
+19,160
New +$971K
REI icon
542
Ring Energy
REI
$391M
$1.01M 0.01%
+937,046
New +$1.31M
NECB icon
543
Northeast Community Bancorp
NECB
$374M
$1.01M 0.01%
36,481
-62,290
-63% -$1.55M
SIGA icon
544
SIGA Technologies
SIGA
$236M
$996K 0.01%
273,522
KHC icon
545
Kraft Heinz
KHC
$29.5B
$984K 0.01%
41,658
-34
-0.1% -$785
T icon
546
AT&T
T
$176B
$969K 0.01%
46,800
TBPH icon
547
Theravance Biopharma
TBPH
$887M
$953K 0.01%
+56,052
New +$928K
NEWT icon
548
NewtekOne
NEWT
$359M
$939K 0.01%
63,433
KMI icon
549
Kinder Morgan
KMI
$69.9B
$887K 0.01%
27,751
-57,938
-68% -$1.87M
PCRX icon
550
Pacira BioSciences
PCRX
$1.05B
$885K 0.01%
34,892
+5,356
+18% +$127K

Similar funds

Segall Bryant & Hamill's Q2 2026 Portfolio in Review

As of Q2 2026, Segall Bryant & Hamill held 678 positions worth $8.43B, up 21% from $6.98B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Segall Bryant & Hamill's Q2 2026 filing shows 102 new, 209 increased, 234 reduced and 88 closed positions. Its largest new stake was Marathon Digital Holdings: 2,756,177 shares worth $38.3M. The largest sale was Onto Innovation, an estimated $45.9M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q2 2026 buy was Marathon Digital Holdings: 2,756,177 shares worth $38.3M.
  • Segall Bryant & Hamill added most to Timken Company in Q2 2026, an estimated $45.3M increase.
  • Segall Bryant & Hamill's biggest Q2 2026 reduction was Onto Innovation, cutting an estimated $45.9M.
  • Segall Bryant & Hamill fully exited Axcelis in Q2 2026, selling an estimated $18.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 13% of its $8.43B portfolio in Q2 2026.
  • Segall Bryant & Hamill opened 102 new positions and closed 88 in Q2 2026.
  • Segall Bryant & Hamill's portfolio value rose 21% quarter-over-quarter to $8.43B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.